Advicenne

Advicenne S.A. is a specialty pharmaceutical company that develops and commercializes safe treatments for rare renal diseases in France and internationally. Its products include Sibnayal for metabolic disorders, Likozam (a clobazam formulation) for short-term symptomatic treatment of severe, disabling, or condition-causing anxiety, and Levidcen (a galenic form of levetiracetam) for epileptic seizures. The company was incorporated in 2007 and is headquartered in Paris, France.